Table 2.
CAC presence OR (95% CI) |
Log IMT β (P-value) |
Lesion presence OR (95% CI) |
|
---|---|---|---|
Log FT | 1.28 (0.80, 2.05) | −0.0003 (0.98) | 0.87 (0.55, 1.38) |
HIV-infected/HIV-uninfected | 1.44 (0.92, 2.24) | −0.004 (0.75) | 1.69 (1.06, 2.71) |
Age | 1.16 (1.12, 1.20) | 0.01 (<0.0001) | 1.10 (1.06, 1.13) |
BMI | 1.04 (0.99, 1.09) | 0.01 (<0.0001) | 1.01 (0.96, 1.06) |
Race (Black) | 0.46 (0.27, 0.79) | 0.06 (<0.0001) | 0.775 (0.45, 1.33) |
Log HOMA-IR | 1.03 (0.72, 1.47) | −0.01 (0.29) | 0.974 (0.68, 1.40) |
Current smoker (yes/no) | 2.44 (1.50, 4.00) | −0.01 (0.69) | 1.942 (1.19, 3.17) |
LDL cholesterol ≥160 mg/dL | 1.84 (1.03, 3.29) | 0.01 (0.44) | 1.05 (0.56, 1.97) |
HDL cholesterol ≤40 mg/dL | 1.36 (0.87, 2.10) | −0.01 (0.68) | 1.08 (0.68, 1.70) |
Hypertension (yes/no) | 1.28 (0.84, 1.95) | 0.04 (0.002) | 1.49 (0.97, 2.29) |
Lipid-lowering agent use | 1.27 (0.79, 2.06) | 0.02 (0.24) | 1.67 (1.02, 2.72) |
BMI, body mass index; CI, confidence interval; FT, free testosterone; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance; LDL, low-density lipoprotein; OR, odds ratio.